Susquehanna Fundamental Investments, LLC Aim Immuno Tech Inc. Put Options Transaction History
Susquehanna Fundamental Investments, LLC
- $6.8 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AIM
# of Institutions
38Shares Held
4.65MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.99MShares$278,4180.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$97,7570.0% of portfolio
-
Geode Capital Management, LLC Boston, MA464KShares$64,9620.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il359KShares$50,2580.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny260KShares$36,4670.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $6.73M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...